Prelude Capital Management, LLC Inari Medical, Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.65 - $65.76 $74,470 - $120,472	1,832 Added 36.88%	6,800 $326,000
Q4 2023 Feb 14, 2024	SELL	$48.3 - $68.06 $376,740 - $530,868	-7,800 Reduced 61.09%	4,968 $322,000
Q3 2023 Nov 14, 2023	BUY	$54.2 - $71.67 $692,025 - $915,082	12,768 New	12,768 $835,000
Q1 2023 May 15, 2023	BUY	$53.43 - $68.12 $428,668 - $546,526	8,023 New	8,023 $495,000
Q2 2022 Aug 15, 2022	SELL	$52.13 - $93.81 $122,296 - $220,078	-2,346 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$64.92 - $99.47 $152,302 - $233,356	2,346 New	2,346 $213,000

283

56.4M

412K

46.7K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $4.27B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.